Kodiak Sciences (KOD) Reports Q4 EPS of ($1.05)

1 week ago 8

Jeff Lewis

Sun, April 12, 2026 astatine 4:18 PM CDT 1 min read

Kodiak Sciences Inc. (NASDAQ:KOD) is 1 of the

8 Healthcare Stocks Insiders Are Buying. On April 1, 2026, Kodiak Sciences Inc. (NASDAQ:KOD) reported Q4 EPS of ($1.05) compared to (84c) past year. Victor Perlroth, M.D., Chief Executive Officer, said momentum is building, citing “positive Phase 3 topline results” from the GLOW2 survey and advancement crossed late-stage and pipeline programs supporting the company’s semipermanent strategy.

On March 27, 2026, UBS raised its terms people connected Kodiak Sciences Inc. (NASDAQ:KOD) to $80 from $50 antecedently and maintained a Buy standing connected the shares. UBS said it is bullish connected some tarcocimab VEGF and IL6.

Kodiak Sciences (KOD) Reports Q4 EPS of ($1.05)

Photo by José Antonio Otegui Auzmendi connected Pexels

Similarly, H.C. Jefferies raised its terms people connected Kodiak Sciences Inc. (NASDAQ:KOD) to $56 from $39 antecedently and maintained a Buy standing connected the shares, noting GLOW2 results showed improved information and efficacy versus GLOW1, with the reformulation seen arsenic a information betterment and imaginable operator of durability successful the Phase III DAYBREAK study, portion besides supporting earlier Biologics License Application timing.

Kodiak Sciences Inc. (NASDAQ:KOD) develops therapies for retinal diseases.

While we admit the imaginable of KOD arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article